» Articles » PMID: 38510743

The Interplay Between Sars-Cov-2 Infection Related Cardiovascular Diseases and Depression. Common Mechanisms, Shared Symptoms

Overview
Journal Am Heart J Plus
Date 2024 Mar 21
PMID 38510743
Authors
Affiliations
Soon will be listed here.
Abstract

In 2020 the World Health organization announced a pandemic due to the outbreak of the Coronavirus disease 19. Pneumonia was the most common manifestation of the Sars-Cov-2 infection, however, clinical papers describe Sars-Cov-2 associated cardiovascular pathologies, such as ACS, myopericarditis, cardiomyopathies, dysrhythmias, as leading causes of increased morbidity and mortality. The short and long term prognosis of Sars-Cov-2-related cardiovascular diseases was defined not only by the disease severity itself but also by associated conditions and complications, among which mental health issues (stress, depression and anxiety) have a negative impact. The interplay between Sars-Cov-2 infection, cardiovascular disease and depression may be explained by hyperinflammation, unhealthy lifestyle and inter-organ communication, mediated by extracellular vesicles (EV) and non-coding MicroRNA (miRNA). The long Covid syndrome is characterized with orthostatic hypotension, impaired cardiac and cerebral perfusion, postural orthostatic tachycardia syndrome (POTS), syncope, chest pain, dyspnea, palpitation, chronic fatigue syndrome, 'brain fog', memory, cognitive and sleep difficulties, depression and anxiety. From a clinical point of view these symptoms may be considered as common symptoms representing not only a cardiac but also a neurological/psychiatric problem. Consequently assessment of these symptoms are of paramount importance. Due to their complexity, management of these patients requires multidisciplinary care.

Citing Articles

Predicting higher risk factors for COVID-19 short-term reinfection in patients with rheumatic diseases: a modeling study based on XGBoost algorithm.

Liang Y, Xie S, Zheng X, Wu X, Du S, Jiang Y J Transl Med. 2024; 22(1):1144.

PMID: 39719617 PMC: 11668030. DOI: 10.1186/s12967-024-05982-2.

References
1.
Pedersen E, Tuseth N, Eussen S, Ueland P, Strand E, Svingen G . Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol. 2014; 35(2):455-62. DOI: 10.1161/ATVBAHA.114.304674. View

2.
Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J . Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-1273. PMC: 7385689. DOI: 10.1001/jamacardio.2020.3557. View

3.
Ramadan M, Bertolino L, Marrazzo T, Florio M, Durante-Mangoni E . Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med. 2021; 16(8):2051-2061. PMC: 8158084. DOI: 10.1007/s11739-021-02763-3. View

4.
Boucas A, Rheinheimer J, Lagopoulos J . Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective. Neuroscientist. 2020; 28(1):11-19. DOI: 10.1177/1073858420967892. View

5.
Mingoti M, Bertollo A, Simoes J, Francisco G, Bagatini M, Ignacio Z . COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci. 2022; 72(6):1166-1181. PMC: 8942178. DOI: 10.1007/s12031-022-02004-y. View